Phase 2 Encephalomyelitis Clinical Trials

4 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–4 of 4 trials

Recruiting

Phase 1Phase 2

Lumbrokinase for Adults With Long Covid, Post-treatment Lyme Disease Syndrome, and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Myalgic EncephalomyelitisChronic Fatigue SyndromePost-treatment Lyme Disease Syndrome+1 more

Icahn School of Medicine at Mount Sinai120 enrolled1 locationNCT06511050

Recruiting

Phase 2

Assessment of N-Acetylcysteine as Therapy for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Myalgic EncephalomyelitisChronic Fatigue Syndrome

Weill Medical College of Cornell University95 enrolled1 locationNCT04542161

Recruiting

Phase 2

Study of the Efficacy and Safety for Rituximab in Myalgia Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)

Myalgia Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)

National Center of Neurology and Psychiatry, Japan30 enrolled1 locationNCT06952413

Recruiting

Phase 2Phase 3

TRI-ME: Trimetazidine to treat Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A double-blind, randomised, placebo-controlled efficacy trial

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Deakin University126 enrolled1 locationACTRN12625000095460